Literature DB >> 2583124

Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding.

S M Zurawski1, G Zurawski.   

Abstract

The function of two alpha-helical regions of mouse interleukin-2 were analyzed by saturation substitution analysis. The functional parts of the first alpha-helix (A) was defined as residues 31-39 by the observation that proline substitutions within this region inactivate the protein. Four residues within alpha-helix A, Leu31, Asp34, Leu35 and Leu38, were found to be crucial for biological activity. Structural modeling suggested that these four residues are clustered on one face of alpha-helix A. Residues 31 and 35 had to remain hydrophobic for the molecule to be functional. At residue 38 there was a preference for hydrophobic side chain residues, while at residue 34 some small side chain residues as well as acidic or amide side chain residues were functionally acceptable. Inactivating changes at residue 34 had no effect upon the ability of the protein to interact with the p55 receptor. Disruption of the fifth alpha-helix (E), which had little effect upon biological activity, resulted in an inability of the protein to interact with the p55 receptor. Mutagenesis of the alpha-helix E region demonstrated that alpha-helicity and the nature of the side chain residues in this region were unimportant for biological activity. The region immediately proximal to alpha-helix E was important only for the single intramolecular disulfide linkage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583124      PMCID: PMC401262          DOI: 10.1002/j.1460-2075.1989.tb08397.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  17 in total

1.  A LOCUS THAT CONTROLS FILAMENT FORMATION AND SENSITIVITY TO RADIATION IN ESCHERICHIA COLI K-12.

Authors:  P HOWARD-FLANDERS; E SIMSON; L THERIOT
Journal:  Genetics       Date:  1964-02       Impact factor: 4.562

2.  Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5.

Authors:  T Yokota; R L Coffman; H Hagiwara; D M Rennick; Y Takebe; K Yokota; L Gemmell; B Shrader; G Yang; P Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Persistence of freely replicating SV40 recombinant molecules carrying a selectable marker in permissive simian cells.

Authors:  L C Tsui; M L Breitman; L Siminovitch; M Buchwald
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity.

Authors:  G Ju; L Collins; K L Kaffka; W H Tsien; R Chizzonite; R Crowl; R Bhatt; P L Kilian
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

Authors:  A Wang; S D Lu; D F Mark
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

8.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA.

Authors:  J Miller; T R Malek; W J Leonard; W C Greene; E M Shevach; R N Germain
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Alterations in the amino-terminal third of mouse interleukin 2: effects on biological activity and immunoreactivity.

Authors:  S M Zurawski; T R Mosmann; M Benedik; G Zurawski
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

View more
  17 in total

1.  Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor.

Authors:  K Sauvé; M Nachman; C Spence; P Bailon; E Campbell; W H Tsien; J A Kondas; J Hakimi; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.

Authors:  A J Grant; E Roessler; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.

Authors:  Kevin R Mott; Mandana Zandian; Sariah J Allen; Homayon Ghiasi
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

4.  Receptor binding properties of four-helix-bundle growth factors deduced from electrostatic analysis.

Authors:  E Demchuk; T Mueller; H Oschkinat; W Sebald; R C Wade
Journal:  Protein Sci       Date:  1994-06       Impact factor: 6.725

5.  Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction.

Authors:  S M Zurawski; J L Imler; G Zurawski
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

6.  Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules.

Authors:  A N McKenzie; S C Barry; M Strath; C J Sanderson
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

7.  Structure-activity relationship study of human interleukin-3: role of the C-terminal region for biological activity.

Authors:  N A Lokker; G Zenke; U Strittmatter; B Fagg; N R Movva
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

8.  Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.

Authors:  N Kruse; H P Tony; W Sebald
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

9.  Receptor antagonist and selective agonist derivatives of mouse interleukin-2.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors.

Authors:  A B Shanafelt; A Miyajima; T Kitamura; R A Kastelein
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.